- China's state-run Xinhua News Agency reports that healthcare providers at Wuhan's Jinyintan Hospital will begin treating the first group of severe coronavirus cases with Gilead Sciences' (GILD -2.2%) remdesivir tomorrow. A total of 761 patients will receive therapy.
- Chinese authorities have OK'd the start of clinical trials.
Recommended For You
More Trending News
See More »